Back to Journals » Therapeutics and Clinical Risk Management » Volume 18

Once-Daily Abrocitinib for the Treatment of Moderate-to-Severe Atopic Dermatitis in Adults and Adolescents Aged 12 Years and Over: A Short Review of Current Clinical Perspectives
Total article views | HTML views | PDF downloads | Totals | ||
---|---|---|---|---|---|
5,867 | Dovepress* | 4,553+ | 318 | 4,871 | |
PubMed Central* | 1,314 | 202 | 1,516 | ||
Totals | 5,867 | 520 | 6,387 | ||
*Since 13 April 2022 |
View citations on PubMed Central and Google Scholar